» Articles » PMID: 25416736

Choosing the Right Dose of Tacrolimus

Overview
Journal Arch Dis Child
Specialty Pediatrics
Date 2014 Nov 23
PMID 25416736
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Choosing the right dose of tacrolimus 'adapted to each individual patient' is a central question after transplantation. The pharmacokinetic behaviour of tacrolimus in paediatric patients is significantly influenced by clinical factors growth and maturation, as well as genetic factors. Large interindividual variability and narrow therapeutic index make dosage individualisation mandatory in children. CYP3A5 expressers require a 1.8-fold higher tacrolimus dose than non-expressers. A visual patient-tailored dosing chart, taking into consideration the child's weight, recent haematocrit level and CYP3A5 genotype, was developed based on a population pharmacokinetic-pharmacogenetic model, and can be used routinely to individualise tacrolimus starting dose. Area under the concentration-time curve-based dosage adaptation through limited sampling strategy and Bayesian estimation is more reliable than trough concentration. Therapeutic drug monitoring and dosage adaptation can be included in routine post-transplantation consultation and should be considered in the urgent situations (eg, rejection, adverse event, lack of compliance, change of coadministration drug with potential drug-drug interaction and other situations).

Citing Articles

Tacrolimus Concentration/Dose Ratio: A Tool for Guiding Tacrolimus Dosage Post-renal Transplantation.

Shenoy M, Manavalan J, A H, K S, Mohanty P Cureus. 2024; 16(2):e53421.

PMID: 38435193 PMC: 10908598. DOI: 10.7759/cureus.53421.


Additive Manufacturing of an Extended-Release Tablet of Tacrolimus.

Abdollahi A, Ansari Z, Akrami M, Haririan I, Dashti-Khavidaki S, Irani M Materials (Basel). 2023; 16(14).

PMID: 37512202 PMC: 10381679. DOI: 10.3390/ma16144927.


Rituximab, Mycophenolic Acid, and Calcineurin Inhibitors Achieve Long-Term Remission in Pediatric Focal Segmental Glomerulosclerosis with Steroid-Resistant and Frequently Relapsing Nephrotic Syndrome: A Report of Two Cases.

Ambarsari C, Saraswati M, Laudza G Case Rep Nephrol Dial. 2022; 12(3):167-177.

PMID: 36518356 PMC: 9743143. DOI: 10.1159/000525776.


Genomewide association study identifies a novel variant associated with tacrolimus trough concentration in Chinese renal transplant recipients.

Yang S, Jiang H, Li C, Lu H, Li C, Ye D Clin Transl Sci. 2022; 15(11):2640-2651.

PMID: 35977080 PMC: 9652447. DOI: 10.1111/cts.13388.


Tacrolimus trough levels in kidney transplant recipients.

Hwang Y, Kim H, Min K, Yang J BMC Nephrol. 2021; 22(1):405.

PMID: 34876046 PMC: 8650372. DOI: 10.1186/s12882-021-02622-5.